Anne Fiquet

Evaluation of non-inferiority of intradermal versus adjuvanted seasonal influenza vaccine using two serological techniques: a randomised comparative study

Pierre Van Damme, Robert Arnou, Froukje Kafeja et al. · BMC Infectious Diseases · 2010 · 85 citations · Full text

Safety of Tdap-IPV given one month after Td-IPV booster in healthy young adults: A placebo-controlled trial

J. Beytout, Odile Launay, Nicole Guiso et al. · Human Vaccines · 2009 · 76 citations · Full text

Immunogenicity and safety of a live attenuated shingles (herpes zoster) vaccine (Zostavax^®) in individuals aged ≥ 70 years: A randomized study of a single dose vs. two different two-dose schedules

Timo Vesikari, Roland Hardt, H. C. Rümke et al. · Human Vaccines & Immunotherapeutics · 2013 · 33 citations · Full text

Immunodeficiencies, Immunology, Disease Protection +18

Challenge with a hepatitis B vaccine in two cohorts of 4–7-year-old children primed with hexavalent vaccines: An open-label, randomised trial in Italy

Alessandro Zanetti, Antonino Parlato, Luisa Romanò et al. · Vaccine · 2012 · 33 citations

Vaccination, Infectious Disease Prevention, Viral Hepatitis +9

13‐valent pneumococcal conjugate vaccine (PCV13) is immunogenic and safe in children 6‐17 years of age with sickle cell disease previously vaccinated with 23‐valent pneumococcal polysaccharide vaccine (PPSV23): Results of a phase 3 study

Mariane de Montalembert, Miguel R. Abboud, Anne Fiquet et al. · Pediatric Blood & Cancer · 2015 · 32 citations